GE HealthCare Technologies PDx — Total Costs & Expenses increased by 3.2% to $573.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 33.9%, from $428.00M to $573.00M. Over 3 years (FY 2022 to FY 2025), PDx — Total Costs & Expenses shows an upward trend with a 12.1% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Rising costs relative to revenue may indicate scaling challenges or increased investment in R&D, while declining costs relative to revenue suggest operational leverage.
The aggregate of all operating costs, including cost of sales, research and development, and selling, general, and admin...
Standard total operating expense metric for business units, comparable across most industrial and healthcare segments.
gehc_segment_pdx_costs_and_expenses| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $359.50M | $359.50M | $359.50M | $359.50M | $422.25M | $422.25M | $422.25M | $422.25M | $421.00M | $439.00M | $432.00M | $433.00M | $428.00M | $516.00M | $529.00M | $555.00M | $573.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +17.5% | +0.0% | +0.0% | +0.0% | -0.3% | +4.3% | -1.6% | +0.2% | -1.2% | +20.6% | +2.5% | +4.9% | +3.2% |
| YoY Change | — | — | — | — | +17.5% | +17.5% | +17.5% | +17.5% | -0.3% | +4.0% | +2.3% | +2.5% | +1.7% | +17.5% | +22.5% | +28.2% | +33.9% |